Peritoneal in Laparoscopic Ventral Hernia Repair 2
BriClo2
Randomised Controlled Trial of Peritoneal Bridging Versus no Defect Closure in Laparoscopic Ventral Hernia Repair
1 other identifier
interventional
115
1 country
1
Brief Summary
Laparoscopic ventral hernia repair (VHR) is usually performed by reducing the contents in the hernia sac from the abdominal cavity and then covering the defect from the inside with a mesh, i.e. Intraperitoneal Onlay Mesh (IPOM). This means that the hernia sac is left in situ anterior to the mesh. This may, however, predispose for the development of fluid in the hernia sac, i.e. seroma. The risk of seroma development may be reduced if a the defect is closed before the mesh is applied. Closing the defect may, however, cause tension and pain from the abdominal wall. Instead of closing the defect, the part of the peritoneum constituting the hernia sac may be used for closing the defect. In this case, the peritoneum is dissected from the edges of the hernia sac and then used as a flap that is fixated to the edges of the hernia sac on the opposite side. In a previous study (BriClo), we compared defect closure as control group with peritoneal bridging. That study showed an increased risk for postoperative pain if the defect was closed. In order to evaluate whether peritoneal bridging reduces the seroma development following ventral hernia repair, we are undertaking a double-blind randomized controlled trial comparing no closure of the defect with peritoneal bridging. The goal is to randomize 100 patients undergoing laparoscopic ventral hernia repair. Clinical follow-up is performed three months, six months and one year after surgery. At all occasions, the patient is requested to fill in the Ventral Hernia Pain Questionnaire (VHPQ) and an investigation is done in order to assess the presence of seromas, recurrences or other local complications. Duration until return to work is registered. One year after surgery, computer tomography is performed in order to quantify the volume of seromas.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_2
Started Mar 2019
Typical duration for phase_2
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2019
CompletedFirst Submitted
Initial submission to the registry
January 13, 2020
CompletedFirst Posted
Study publicly available on registry
January 18, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2021
CompletedMarch 31, 2022
March 1, 2022
1.8 years
January 13, 2020
March 30, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Seroma volume
Volume of postoperative seroma measured with ultrasound
One year
Secondary Outcomes (4)
Postoperative complications
30 days
Postoperative pain
One year
Operative time
3 hours
Hernia recurrence
One year
Study Arms (2)
Peritoneal bridging
EXPERIMENTALThe peritoneum is dissected beginning 2-3 cm from the edge of the defect. The sac is dissected all the way to the opposite edge of the defect. The peritoneal flap is pulled to the opposite side and fixated with Optifix
No bridging
ACTIVE COMPARATORThe hernia defect is left without closure prior to application of the mesh.
Interventions
Eligibility Criteria
You may qualify if:
- Patients planned for laparoscopic ventral hernia repair
- Defect size 3-10 cm
- BMI \<40
You may not qualify if:
- Defect size \>10 cm
- Ventral hernias with other localization than the midline
- Emergency surgery and incarcerated hernias
- Preoperative anticipation of extensive adhesions
- Pregnancy or intended pregnancy
- Serious comorbidity (ASA score \>3)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Karolinska Institutetlead
- Region Örebro Countycollaborator
Study Sites (1)
Department of Surgery, Karloskoga Hospital
Karlskoga, 69144, Sweden
Related Publications (1)
Ali F, Sandblom G, Forgo B, Wallin G. Peritoneal Bridging Versus Nonclosure in Laparoscopic Ventral Hernia Repair: A Randomized Controlled Trial. Ann Surg Open. 2023 Feb 2;4(1):e257. doi: 10.1097/AS9.0000000000000257. eCollection 2023 Mar.
PMID: 37600866DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- The patient undergoing surgery and the physician performing the follow-up are masked to the allocation.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
January 13, 2020
First Posted
January 18, 2020
Study Start
March 1, 2019
Primary Completion
December 31, 2020
Study Completion
December 31, 2021
Last Updated
March 31, 2022
Record last verified: 2022-03
Data Sharing
- IPD Sharing
- Will not share